Presentation is loading. Please wait.

Presentation is loading. Please wait.

Autologous versus Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation for Patients with Chemosensitive Follicular Non-Hodgkin Lymphoma beyond.

Similar presentations


Presentation on theme: "Autologous versus Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation for Patients with Chemosensitive Follicular Non-Hodgkin Lymphoma beyond."— Presentation transcript:

1 Autologous versus Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation for Patients with Chemosensitive Follicular Non-Hodgkin Lymphoma beyond First Complete Response or First Partial Response  Marcie R. Tomblyn, Marian Ewell, Christopher Bredeson, Brad S. Kahl, Stacey A. Goodman, Mary M. Horowitz, Julie M. Vose, Robert S. Negrin, Ginna G. Laport  Biology of Blood and Marrow Transplantation  Volume 17, Issue 7, Pages (July 2011) DOI: /j.bbmt Copyright © 2011 American Society for Blood and Marrow Transplantation Terms and Conditions

2 Figure 1 OS (A) and PFS (B) after allogeneic and autologous HCT for FL. Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt ) Copyright © 2011 American Society for Blood and Marrow Transplantation Terms and Conditions


Download ppt "Autologous versus Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation for Patients with Chemosensitive Follicular Non-Hodgkin Lymphoma beyond."

Similar presentations


Ads by Google